Description
LSPN451, was selected from a series of 10 synthetic derivatives, is a novel potent xanthine oxidase inhibitor may be potentially useful for the treatment of hyperuricemia and gout. Xanthine oxidase inhibition (XOI) reduces oxidative stress in the vasculature